ARTICLES BY MATHINI ILANCHERAN
-
![Finance business trade economy-GettyImages-2230458034]( "U.S. Pharma Tariffs And MFN Become Law After April 2 Update")
U.S. Pharma Tariffs And MFN Become Law After April 2 Update4/15/2026Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.
-
![Various Pills on White Stripes of American Flag-GettyImages-172849908]( "U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact")
U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact2/18/2026Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.
-
![India and us flags-GettyImages-1089423548]( "Global Implications Of Zero Tariffs On Indian Pharma Exports To China")
Global Implications Of Zero Tariffs On Indian Pharma Exports To China11/5/2025Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
![big pharma, private equity funds-GettyImages-2208792176]( "100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing")
100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing10/17/2025Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.
-
![Law book with a gavel - 2022 GettyImages-1355117041]( "India's New Drugs, Medical Devices, And Cosmetics Draft Bill 2022")
India's New Drugs, Medical Devices, And Cosmetics Draft Bill 202211/7/2022To accommodate changing requirements and encourage the adoption of new technology, India’s Ministry of Health and Family Welfare released a draft bill in July 2022 to replace the existing Drugs and Cosmetics Act 1940. What are the major areas of change and how much of an impact will there be?
